Director Daniel N. Swisher Jr. resigns from Protagonist board; board reduced to six

Protagonist Therapeutics, Inc

Daniel N. Swisher Jr. resigned from the Board effective September 17, 2024; no disagreement with company operations.
Swisher will continue as an advisor to the company under an advisory agreement.
Sarah A. O'Dowd appointed to the Audit Committee effective September 19, 2024.
Board size reduced from seven to six members concurrent with Swisher's resignation.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel N. Swisher Jr.

Member of the Board of Directors

PTGX · Protagonist Therapeutics, Inc

Effective: 2024-09-17
Filed: September 20, 2024, 7:59 PM ET

On September 17, 2024, Daniel N. Swisher Jr., a member of the Board of Directors (the “Board”) of Protagonist Therapeutics, Inc. (the “Company”) and a member of the Audit Committee of the Board, resigned from the Board, effective September 17, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Daniel N. Swisher Jr. resigned as Member of the Board of Directors at Protagonist Therapeutics, Inc.

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

On September 17, 2024, Daniel N. Swisher Jr., a member of the Board of Directors (the “Board”) of Protagonist Therapeutics, Inc. (the “Company”) and a member of the Audit Committee of the Board, resigned from the Board, effective September 17, 2024.

View on SEC.gov

Protagonist Therapeutics, Inc filing history →

Source: SEC EDGAR

accession 0001104659-24-101688

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.